Skip to main content
. Author manuscript; available in PMC: 2014 Apr 1.
Published in final edited form as: Cancer Epidemiol Biomarkers Prev. 2013 Mar 5;22(4):485–495. doi: 10.1158/1055-9965.EPI-13-0010

Figure 2. Incorporating Molecular Epidemiology and Biomarkers in the Multilevel Framework.

Figure 2

Biological levels include inherited genome (IG), somatic genome (SG), as well as related biomarkers of biologically effective dose (BED), biomarkers of early biological effect (EBE), and biomarkers of altered structure and function (ASF) (41).